4D Pharma Joins The SPAC Trend To Fund Its Keytruda-Boosting Biotherapeutic

A Platform To Attract More Investors

 
• By Andrew McConaghie
  
Nasdaq 2021
The company joins a trend for SPAC biotech mergers which gained momentum last year and has continued into 2021
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip